Jamieson Wellness Inc., a Canadian vitamin and natural health products company, is exploring a potential sale and has enlisted the help of BMO Capital Markets and Canaccord Genuity to advise on its options. This move comes as the company seeks to capitalize on growing interest in the health and wellness sector.
The Toronto-based firm, which has been making vitamins in Canada since 1922, has reportedly attracted preliminary interest from several potential buyers. The discussions are still in early stages, and there is no guarantee that a transaction will materialize. The company's strong brand recognition and established market presence are key assets that could appeal to strategic investors or private equity firms.
Jamieson Wellness previously explored a sale in 2016, with its then-owner, U.S. buyout firm CCMP Capital Advisors, seeking a valuation of up to $1 billion. However, that auction was ultimately scrapped. The company instead went public in 2017, raising approximately C$300 million in its initial public offering on the Toronto Stock Exchange.
In its latest reported financial results for the first quarter of 2026, Jamieson Wellness reported a significant increase in consolidated revenue by 16.3% to $169.8 million, with particular strength in its Jamieson Brands and Strategic Partners segments. The company also announced a 55% growth in its China business, along with overall gross profit growth of $13.9 million to $69.1 million, driven by higher revenue and margin expansion. This strong performance could be a factor in the timing of the current exploration of sale options.
